Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Neurodegenerative Disease
Target ALS launches new data portal for research
By
Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024
Skin biopsy test shows promise for detection of neurogenerative diseases
By
Matt Limb
A simple skin biopsy test has shown a high accuracy rate in detecting an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson's disease and other synucleinopathies, say neurologists.
April 5, 2024
U.K. team develops new approach to detect signs of motor neuron disease
By
Matt Limb
Scientists have identified a new way to detect signs of motor neuron disease (MND) in brain tissue, raising hopes for early diagnosis and intervention before onset of symptoms.
April 3, 2024
Myrobalan Therapeutics completes $24M series A financing round
By
LabPulse.com staff writers
Biotech company Myrobalan Therapeutics completed a $24 million series A financing round Wednesday.
January 11, 2024
CRISPR-Cas3 technique restores dystrophin function in iPSCs from DMD patients
By
Maryam Payne
Researchers have developed a dual CRISPR-Cas3 gene editing technique to restore dystrophin function in induced pluripotent stem cells (iPSCs) from patients with Duchenne muscular dystrophy (DMD).
August 24, 2023
Scientists discover genetic variant linked to speed of multiple sclerosis progression
By
Nick Paul Taylor
The analysis of seven million genetic variants enabled the scientists to identify a variant associated with faster disease progression.
June 30, 2023
Gut bacteria changes in preclinical Alzheimer’s suggest ways to detect, delay disease
By
Nick Paul Taylor
Earlier studies found that the gut microbiomes of people with symptomatic Alzheimer’s differ from those of healthy people of the same age, but were unable to tell how early the divergence begins.
June 14, 2023
Serum assay may enable the diagnosis of neurodegenerative diseases
By
Elissa Wolfson
An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.
May 30, 2023
CND Life Sciences closes $4.5M seed financing round
By
LabPulse.com staff writers
The funding is intended to accelerate the commercialization of the Syn-One test that identifies abnormal alpha-synuclein aggregation in cutaneous nerves through a skin biopsy.
April 6, 2023
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
By
LabPulse.com staff writers
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Fluorescent RNA enables real time detection of neurodegenerative disease driver in live cells
By
Nick Paul Taylor
Researchers have found an RNA structure associated with a neurodegenerative disease in live cells using a technique based on fluorescence-microscopic spectroscopy.
February 7, 2023
State of Arizona awards CND Life Sciences $4.2 million to develop neurodegenerative biosignatures library
By
LabPulse.com staff writers
With the funds from the Governor's Office, CND plans to develop and open the Digital Biosignatures Lab in 2023 adjacent to its headquarters, adding AI-driven image analysis and other digital tools to the company’s cutaneous neurodiagnostic technology.
December 28, 2022
Page 1 of 2
Next Page